Advertisement
Video ThumbnailVideo Thumbnail
Updated: Jun 30, 2020, 09:35 PM IST

COVID-19 Vaccine India’s COVAXIN gets DCGI approval for human clinical trials

The Drug Controller General of India has allowed Bharat Biotech India (BBIL) to conduct human clinical trials for ‘COVAXIN’, a potential COVID-19 vaccine. The human clinical trials will start across India in July 2020. If it emerges successful, COVAXIN will be available by year’s end.

Advertisement

The Drug Controller General of India has allowed Bharat Biotech India (BBIL) to conduct human clinical trials for ‘COVAXIN’, a potential COVID-19 vaccine. The human clinical trials will start across India in July 2020. If it emerges successful, COVAXIN will be available by year’s end.

Read More
Advertisement
Advertisement
Advertisement